ORAGENICS, INC. Current Assets
ORAGENICS, INC. (OGEN) had Current Assets of $5.49 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-13
- 2026-06-30: Assets, Current $5.49M.
- 2026-03-31: Assets, Current $7.49M.
- 2025-12-31: Assets, Current $10.07M.
- 2025-09-30: Assets, Current $12.71M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $5.49M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $7.49M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $10.07M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $12.71M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $2.14M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $3.87M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $1.47M 10-K · filed 2026-03-16 | |
| 2024-09-30 | $4.11M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $1.62M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $2.44M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $3.87M 10-K · filed 2025-03-14 | |
| 2023-09-30 | $7.81M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $8.10M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $11.70M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $14.29M 10-K · filed 2024-03-29 | |
| 2022-09-30 | $16.52M 10-Q/A · filed 2023-04-14 | $14.51M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $19.86M 10-Q/A · filed 2023-04-14 | $17.97M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $23.09M 10-Q/A · filed 2023-04-14 | $21.65M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $27.71M 10-K · filed 2023-04-17 | |
| 2021-09-30 | $30.54M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $34.66M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $36.72M 10-Q · filed 2021-05-03 | |
| 2020-12-31 | $17.98M 10-K/A · filed 2022-07-29 | |
| 2020-09-30 | $10.53M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $9.92M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $14.70M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $18.84M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $22.85M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $26.08M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $31.07M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $21.93M 10-K · filed 2020-03-04 | |
| 2018-09-30 | $15.47M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $5.20M 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $5.48M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $7.19M 10-K · filed 2019-03-29 | |
| 2017-09-30 | $5.10M 10-Q · filed 2017-10-31 | |
| 2017-06-30 | $4.53M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $2.28M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $4.22M 10-K · filed 2018-02-16 | |
| 2016-09-30 | $5.29M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $6.03M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $3.83M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $5.64M 10-K · filed 2017-02-27 | |
| 2015-09-30 | $7.23M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $8.52M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $9.59M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $11.02M 10-K · filed 2016-03-30 | |
| 2014-09-30 | $12.28M 10-Q · filed 2014-11-03 | |
| 2014-06-30 | $13.30M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $15.10M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $16.80M 10-K · filed 2015-02-27 | |
| 2013-09-30 | $8.78M 10-Q · filed 2013-10-25 | |
| 2013-06-30 | $7.02M 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $8.76M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $10.40M 10-K · filed 2014-02-28 | |
| 2012-09-30 | $12.49M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $1.87M 10-Q · filed 2012-08-10 | |
| 2012-03-31 | $1.81M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $1.12M 10-K · filed 2013-03-26 | |
| 2011-09-30 | $1.06M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $1.12M 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $1.50M 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |